no long-term follow-up data is available yet on hospitalised patients.In 2 studies from the US, significant left ventricular ( LV) fibrosis has been described in a high percentage of those children admitted to hospital, with a small percentage of these having non-sustained ventricular tachycardia ( VT) Myocarditis – a very small number of those with this condition have been admitted to hospital. myocarditis and pericarditis following vaccination is usually mild or stable and patients typically recover fully without medical treatment.patients who develop symptoms have usually been vaccinated with a mRNA vaccine (Pfizer/BioNTech or Moderna).most patients who develop symptoms do so within a week of vaccination.this is a very rare condition following vaccination (see the Medicines and Healthcare products Regulatory Agency’s ( MHRA) monthly summary for the latest data).Contributions from RCGP and RCEM have ensured that the recommendations made are practical and risk proportionate.īackground to myocarditis and pericarditis after COVID-19 vaccination and guidelines: This document has been formulated as practical guidance for use by healthcare professionals in the NHS. It is a living document and will be reviewed and updated as further data becomes available. This clinical guidance has been endorsed by the British Congenital Cardiac Association ( BCCA). The UK Health Security Agency ( UKHSA), in partnership with the Royal College of General Practitioners ( RCGP) and the Royal College of Emergency Medicine ( RCEM), has produced this clinical guidance to support the detection and management of clinical cases of myocarditis and pericarditis associated with coronavirus (COVID-19) vaccination.
0 kommentar(er)
